These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29879903)

  • 21. Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in mouse, rat, and pooled human hepatocytes.
    Heintz MM; Klaren WD; East AW; Haws LC; McGreal SR; Campbell RR; Thompson CM
    Toxicol Sci; 2024 Jun; 200(1):165-182. PubMed ID: 38574381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast Growth Factor Signaling Controls Liver Size in Mice With Humanized Livers.
    Naugler WE; Tarlow BD; Fedorov LM; Taylor M; Pelz C; Li B; Darnell J; Grompe M
    Gastroenterology; 2015 Sep; 149(3):728-40.e15. PubMed ID: 26028580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in mice.
    Ernst MC; Sinal CJ; Pollak PT
    Pharmacol Res; 2010 Nov; 62(5):408-15. PubMed ID: 20654716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species-specific kinetics and zonation of hepatic DNA synthesis induced by ligands of PPARalpha.
    Al Kholaifi A; Amer A; Jeffery B; Gray TJ; Roberts RA; Bell DR
    Toxicol Sci; 2008 Jul; 104(1):74-85. PubMed ID: 18375545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism.
    van Diepen JA; Jansen PA; Ballak DB; Hijmans A; Hooiveld GJ; Rommelaere S; Galland F; Naquet P; Rutjes FP; Mensink RP; Schrauwen P; Tack CJ; Netea MG; Kersten S; Schalkwijk J; Stienstra R
    J Hepatol; 2014 Aug; 61(2):366-72. PubMed ID: 24751833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PPARα Agonist Fenofibrate Prevents Formation of Protein Aggregates (Mallory-Denk bodies) in a Murine Model of Steatohepatitis-like Hepatotoxicity.
    Nikam A; Patankar JV; Somlapura M; Lahiri P; Sachdev V; Kratky D; Denk H; Zatloukal K; Abuja PM
    Sci Rep; 2018 Aug; 8(1):12964. PubMed ID: 30154499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Fenofibrate on the Expression of Small Heterodimer Partner (SHP) and Cytochrome P450 (CYP) 2D6.
    Kent R; Jeong H
    Drug Metab Lett; 2017 Nov; 11(1):68-72. PubMed ID: 28403802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice.
    Kondo K; Sugioka T; Tsukada K; Aizawa M; Takizawa M; Shimizu K; Morimoto M; Suematsu M; Goda N
    Adv Exp Med Biol; 2010; 662():77-82. PubMed ID: 20204774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats.
    Mohamed DI; Elmelegy AA; El-Aziz LF; Abdel Kawy HS; El-Samad AA; El-Kharashi OA
    Eur J Pharmacol; 2013 Dec; 721(1-3):35-42. PubMed ID: 24140572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGF21 mediates the protective effect of fenofibrate against acetaminophen -induced hepatotoxicity via activating autophagy in mice.
    Zhang Y; Pan Y; Xiong R; Zheng J; Li Q; Zhang S; Li X; Pan X; Yang S
    Biochem Biophys Res Commun; 2018 Sep; 503(2):474-481. PubMed ID: 29730296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into the role of hepatocyte PPARα activity in response to fasting.
    Régnier M; Polizzi A; Lippi Y; Fouché E; Michel G; Lukowicz C; Smati S; Marrot A; Lasserre F; Naylies C; Batut A; Viars F; Bertrand-Michel J; Postic C; Loiseau N; Wahli W; Guillou H; Montagner A
    Mol Cell Endocrinol; 2018 Aug; 471():75-88. PubMed ID: 28774777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt.
    Jia Y; Wu C; Kim J; Kim B; Lee SJ
    J Nutr Biochem; 2016 Feb; 28():9-18. PubMed ID: 26878778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linalool is a PPARα ligand that reduces plasma TG levels and rewires the hepatic transcriptome and plasma metabolome.
    Jun HJ; Lee JH; Kim J; Jia Y; Kim KH; Hwang KY; Yun EJ; Do KR; Lee SJ
    J Lipid Res; 2014 Jun; 55(6):1098-110. PubMed ID: 24752549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
    Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
    Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of hepatic VLDLR via PPARα is required for the triglyceride-lowering effect of fenofibrate.
    Gao Y; Shen W; Lu B; Zhang Q; Hu Y; Chen Y
    J Lipid Res; 2014 Aug; 55(8):1622-33. PubMed ID: 24899625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice.
    Blednov YA; Black M; Benavidez JM; Stamatakis EE; Harris RA
    Alcohol Clin Exp Res; 2016 Mar; 40(3):553-62. PubMed ID: 26857685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of fenofibrate on hepatocyte apoptosis in nonalcoholic fatty liver].
    Zhu Y; Wu J; Zheng Q; Dong J; Jiang J
    Zhonghua Gan Zang Bing Za Zhi; 2015 Sep; 23(9):688-93. PubMed ID: 26524364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms and metabolic regulation of PPARα activation in Nile tilapia (Oreochromis niloticus).
    Ning LJ; He AY; Li JM; Lu DL; Jiao JG; Li LY; Li DL; Zhang ML; Chen LQ; Du ZY
    Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1036-1048. PubMed ID: 27320014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPARα agonist, fenofibrate, ameliorates age-related renal injury.
    Kim EN; Lim JH; Kim MY; Kim HW; Park CW; Chang YS; Choi BS
    Exp Gerontol; 2016 Aug; 81():42-50. PubMed ID: 27130813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.
    McCarthy TC; Pollak PT; Hanniman EA; Sinal CJ
    J Pharmacol Exp Ther; 2004 Dec; 311(3):864-73. PubMed ID: 15265979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.